Cardiac imaging for risk stratification in asymptomatic diabetes Scholte, A.J.H.A.

Hele tekst

(1)Cardiac imaging for risk stratification in asymptomatic diabetes Scholte, A.J.H.A.. Citation Scholte, A. J. H. A. (2009, November 19). Cardiac imaging for risk stratification in asymptomatic diabetes. Retrieved from https://hdl.handle.net/1887/14368 Version:. Corrected Publisher’s Version. License:. Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded from:. https://hdl.handle.net/1887/14368. Note: To cite this publication please use the final published version (if applicable)..

(2) Chapter. 7.

(3) . . .

(4)

(5)

(6)

(7) ! ""#

(8) . $ %

(9) &'. .

(10) Chapter 7. Abstract Background (

(11) )

(12)

(13)

(14)

(15) % #

(16) *$+ ,- ,!) !- )-

(17) with type 2 diabetes has been previously described. However, whether there is a link

(18) 1

(19)

(20) $,- ,

(21)

(22) 13 ,

(23) !

(24) )

(25)

(26) ,1

(27) #

(28) 1

(29)

(30) $, ,-

(31) )

(32)

(33) ,

(34)

(35) ,

(36)

(37) ,)

(38) 5

(39) -)-

(40) ) #

(41)

(42) !

(43) !- #

(44)

(45)

(46)

(47) -

(48) -, )-

(49) 3 Methods 579,!) !- ,)

(50) 5

(51)

(52) !

(53). )-

(54) 1 #

(55) $, ,- :; !

(56) ,

(57)

(58)

(59) $

(60)

(61) - - #

(62) 1

(63) ,

(64) , !*<<+ 5=!

(65) *5+

(66) ),3$ *$+1

(67)

(68) !

(69) - !*>?+3 Results @-

(70) 1 ,

(71)

(72) *<<A;+*BC7D+ !

(73) !)

(74) $ !)

(75) )-

(76) 1 ,

(77)

(78) *<<B;+ *BDE+ *=C:3; F 53: % vs. -16.3 ± 3.0 %, pM;3;;C+3 ! -#

(79) , !

(80)

(81)

(82) ,)

(83)

(84) ,)

(85)

(86)

(87)

(88) !$1

(89)

(90)

(91) )

(92)

(93) ,

(94) 1 ,

(95)

(96) 3(

(97) - $

(98)

(99)

(100)

(101)

(102) )

(103)

(104) #

(105) N ,!) #

(106)

(107) , )

(108) ,

(109)

(110)

(111)

(112) )-

(113) *F2 BE:3D5OpB;3;;C+3 Conclusion !)

(114) )-

(115) 1 ,

(116)

(117)

(118) -)-

(119) 1 ,

(120)

(121) 1

(122) !

(123) !)

(124) $3(

(125) )

(126)

(127)

(128) $, ,- ) #

(129) N

(130) !

(131) #

(132)

(133)

(134) -N- )-

(135) #ing coronary atherosclerosis.. 84.

(136)

(137)

(138)

(139)

(140) . < # !) - ,

(141) ,

(142)

(143) *<+

(144)

(145)

(146) causes of morbidity and mortality in individuals with type 2 diabetes.6 The poor clinical !

(147) )-

(148) 1

(149)

(150)

(151)

(152)

(153)

(154)

(155)

(156) #

(157) ))- ))

(158)

(159)

(160) -<

(161) ,

(162)

(163) ,-- )) )

(164)

(165) !

(166) 1 )

(167) -. ,!,Q

(168) # ,

(169) 1

(170) ) !

(171) 357 1

(172) #

(173)

(174)

(175)

(176) - <)-

(177) 1

(178)

(179)

(180) !.

(181)

(182)

(183) < %

(184) ,!) !-3 ##

(185)

(186) !

(187)

(188) ,

(189) , !*<<+

(190) ,!

(191)

(192)

(193) =

(194) ! !)

(195) ! ), ! -

(196) !)

(197) ! ),*S<(+ invasive imaging of the coronary arteries, by means of MSCT coronary angiography, and myocardial perfusion imaging, by means of single photon emission computed tomog),*@"<(+ #

(198)

(199)

(200)

(201)

(202) ,) )

(203) !) #

(204)

(205) -N- ,!) !-

(206) -)-

(207) = #

(208) #

(209) 336, 43, 84

(210)

(211) ,

(212) ! -

(213)

(214) %#

(215) *$+, - #

(216)

(217)

(218)

(219) )

(220) )-

(221) 1 ,)

(222) 5

(223)

(224) !

(225) - ! *>?+ novel method based on 2-dimensional speckle-tracking echocardiography.98 However, ,!) !-

(226) -)-

(227)

(228)

(229) -

(230) 1

(231)

(232) $, ,-

(233) )

(234)

(235)

(236) ,

(237)

(238) -.

(239) 3 ,

(240) ))

(241)

(242) )

(243)

(244) ,1

(245) #

(246) 1

(247)

(248) $, ,- is independently related to coronary atherosclerosis and if it could provide incremen !- #

(249)

(250)

(251)

(252) -

(253)

(254) -N- ,!) !-

(255) -)-

(256) #<3>?1

(257)

(258) -,

(259) )

(260)

(261)

(262) $ , ,- 1

(263)

(264) )

(265)

(266)

(267) ,

(268)

(269) 1

(270)

(271) , means of CAC scoring.. Methods 5:D

(272) -#

(273) ,!) !- )-

(274) 1 ,)

(275) 5

(276)

(277)

(278) 1

(279) <<

(280)

(281) <3(1 =!

(282)

(283) ),1)

(284) !

(285) . )-

(286)

(287) !

(288) ,3@-

(289) 1 =

(290) Z#

(291) ,!) ! , < !, ) , N *!

(292)

(293)

(294) #

(295)

(296) + # #

(297)

(298)

(299)

(300)

(301)

(302)

(303) , !

(304) - ! -

(305) 85.

(306) Chapter 7. 1

(307)

(308)

(309) '

(310) 3?- )-

(311) 1

(312)

(313)

(314) '

(315)

(316) )-!

(317) )1 13,!) !- 1 N!

(318)

(319)

(320) Z

(321) -

(322) angina.15 , <1

(323) N

(324)

(325) )

(326)

(327)

(328) )

(329) #

(330) ,, !

(331) )

(332)

(333) ,

(334) # [- ). , !

(335)

(336) ,

(337) \E;] ! !

(338)

(339) 367 Hypertension was considered if , )

(340)

(341) 1\C9;!! )

(342)

(343) 1\D;!! )-

(344) 1

(345)

(346) -,)

(347)

(348) #

(349)

(350) !

(351)

(352)

(353)

(354) )

(355)

(356) #

(357) 3,)

(358)

(359)

(360)

(361) !1

(362) N

(363) ,

(364)

(365)

(366) #

(367) AE3;!! ^$

(368)

(369)

(370) 1

(371) !

(372) - 3?- :;

(373) 1

(374)

(375) 1

(376)

(377) included in the present study as control group. The subjects of the control group were !

(378) ,

(379)

(380)

(381) $

(382)

(383) - - *$">+>!!

(384)

(385) 360(

(386)

(387) !

(388) -

(389)

(390) '

(391) 1

(392)

(393) ))

(394)

(395) )3 < #

(396) 1

(397) << 5

(398) ), on the same day.. << 1)

(399) !

(400) _9=

(401) S<(

(402) *Z _9 ( S

(403) ,

(404) ! ( , )+3> ))

(405)

(406)

(407) 1

(408) "<=

(409) 1 )

(410) !

(411) 1 ) )

(412) -#

(413)

(414) `E]

(415) =

(416) # 3)!

(417)

(418) 1

(419)

(420) . 1q. !- 9'73;!! , - -!

(421) ;3E

(422)

(423)

(424) 5;;= 5E;!

(425) #

(426) C5; 3<<

(427) 1

(428)

(429) !

(430) ,

(431) ')

(432)

(433)

(434)

(435) #

(436)

(437)

(438) %1

(439) *

(440) 5 ?!

(441) S

(442) S

(443) x+3 ( <<

(444) 1

(445)

(446) )-

(447)

(448) !

(449) 399 The presence of ,

(450)

(451) 1

(452) N

(453) <<

(454) A;3. !" # (1 =!

(455)

(456) ),1)

(457) !

(458) 1

(459) )-

(460)

(461)

(462) %

(463)

(464) ) - !!

(465) . ,#

(466) ,

(467) !*#`

(468)

(469) "

(470) !

(471) S 1

(472)

(473) x+

(474) Z))

(475) 1 73E=S[

(476) 3 S= !

(477) 5=!

(478) !

(479) ))

(480) = ))

(481) 1

(482)

(483) Z

(484) !

(485) )

(486) ) #

(487) 1*9= 5=7=!

(488) + . ,

(489)

(490) = ) ! 3 ,

(491) 1

(492)

(493) )

(494) !

(495) z

(496) " @<#

(497) `3;3;*"

(498)

(499)

(500) 1,+3$!

(501)

(502)

(503) =

(504)

(505)

(506) #

(507)

(508) ) ! 86.

(509)

(510)

(511)

(512)

(513) . and the posterior wall were measured on the parasternal long-axis M-mode recordings. $

(514) =,

(515) = # !

(516) 1

(517)

(518)

(519)

(520) $">1

(521) !

(522) ) 9=5=!

(523) #

(524) 1

(525) !) |

(526) 3100

(527) Z

(528) , $! 1

(529)

(530) !

(531)

(532) ! ,

(533) #

(534)

(535) '

(536) ! [

(537) ,

(538)

(539) *$!

(540) ' ^!2+3101&

(541)

(542)

(543) !!

(544) -

(545) !

(546)

(547) , " ), ! ) ! , #

(548) } 1 1

(549)

(550)

(551) #

(552) 1 )

(553) = 1#

(554) ))

(555) 3102?-

(556) ,*"+

(557) *+ 1#

(558)

(559)

(560)

(561) - -!

(562) *(+ "1#

(563) ) ! ,#

(564) , *@+ *@+#

(565) -

(566) 1

(567)

(568)

(569) 3 - 1

(570) N

(571) ! 1

(572)

(573) "^- B 0.9-1.5, ( B C_;=59; ! @ \ @3103 (

(574) $

(575) % #

(576) *$+ 1

(577)

(578) z

(579) *" @<#

(580) `3;3;+>?)

(581) # ,

(582)

(583) 314, 104(

(584) %1

(585) ,[

(586) ! - , )

(587)

(588) * -!

(589) +

(590) 5 !

(591) 3(

(592) !

(593) = =!

(594)

(595)

(596) )

(597)

(598)

(599)

(600)

(601) #

(602) ! - #

(603) ,3> ))

(604)

(605)

(606) ,

(607)

(608)

(609)

(610) !

(611) $) #

(612) 1 *) =' 9=5=!

(613) #

(614) 1+3S

(615) !

(616)

(617)

(618)

(619) !

(620) 1 `;)*

(621) 9;=C;;)+3 >

(622)

(623) =, !

(624)

(625) N

(626)

(627) ) ='#

(628) 13(

(629)

(630)

(631) -# #

(632) !

(633)

(634) %1

(635) !

(636)

(637)

(638) -!

(639)

(640) #

(641) 1

(642)

(643) 1#

(644) -# #

(645)

(646) 3(

(647) #

(648)

(649)

(650)

(651)

(652)

(653) 9=5=!

(654) #

(655) 1. )3%

(656)

(657) N

(658) !

(659) $)

(660) '1 7

(661) ')

(662)

(663) = systolic frame in each apical view, the automated algorithm traces 3 concentric lines on the endocardial border, the mid-myocardial layer and epicardial border, including the

(664) -

(665) !, 1. 3(

(666) !. 1

(667)

(668) ! !

(669) frame throughout the cardiac cycle, and allows for a further manual adjustment of the region of interest to ensure that all myocardial regions are included throughout the car,

(670) 3(

(671) $#

(672) _

(673) !

(674)

(675) ) #

(676) 1

(677) Z , validated for each segment. >. ,

(678) !

(679) ! C`=

(680) !

(681) !

(682) ) #

(683)

(684) )

(685) , .

(686) $

(687) !

(688) ~.

(689) ,

(690) ) 1

(691) #

(692)

(693) #

(694) )

(695) ,

(696) #

(697) 1

(698) #

(699)

(700) $

(701)

(702) -

(703)

(704) % #

(705)

(706) 3?

(707)

(708) $$#

(709)

(710) )

(711)

(712)

(713)

(714) -#

(715) #

(716) O!

(717)

(718) -#

(719) value indicates a larger extent of longitudinal strain. The intra- and interobserver agree!

(720) $!

(721)

(722) !

(723)

(724)

(725)

(726) )

(727) )

(728) # , 1

(729) -

(730)

(731) ;3DE =

(732) #

(733) !) ;3D5

(734) =

(735) #

(736) !)sons. 87.

(737) Chapter 7. (

(738) ,) ) - 1#

(739)

(740)

(741)

(742) )

(743)

(744)

(745) ,

(746)

(747) 3< - #

(748)

(749)

(750) ')

(751)

(752) !

(753)

(754) #- *+

(755) #

(756)

(757)

(758) ')

(759)

(760) !

(761) )

(762)

(763)

(764) 3Q

(765)

(766)

(767) -

(768) #

(769)

(770) 1

(771)

(772) )-

(773) 1 1 ,

(774)

(775) 1

(776)

(777)

(778)

(779)

(780)

(781) =

(782)

(783) =Z

(784)

(785)

(786) )

(787) -#

(788) ,3< !) among groups were performed using the one-way analysis of variance test with Bonfer ) = ,3 x#

(789) ! -#

(790) -

(791)

(792) , *

(793)

(794) !

(795) +1

(796)

(797) )

(798) !

(799)

(800) #

(801)

(802) -

(803) 1

(804)

(805)

(806) )

(807)

(808)

(809) ,

(810)

(811)

(812)

(813) *

(814)

(815)

(816) ,

(817)

(818) =

(819)

(820) !) - +

(821) )*$!

(822) ' $"> )

(823)

(824)

(825) ,- $+

(826) -3 ,N *pM;3;E+#

(827) )

(828) 1

(829)

(830)

(831)

(832)

(833) #

(834)

(835) ! -#

(836) !

(837) 3- DE] N

(838)

(839)

(840) # 1

(841)

(842)

(843) 3?

(844)

(845)

(846) !

(847)

(848) )

(849) -

(850) !

(851) #

(852) $$ #

(853)

(854)

(855)

(856)

(857)

(858)

(859) )

(860)

(861) )

(862) ,

(863)

(864)

(865) =Z

(866) -

(867) ! -#

(868) !

(869) 1 !)

(870) 1 =Z

(871) -

(872) !

(873) !

(874) 1 $$ )) ,

(875) !

(876) =Z

(877)

(878) )3 ?-

(879) )-! = Q#

(880) $$ )

(881) ,

(882)

(883) ,!) !- ,)

(884) 5

(885)

(886) )-

(887) 1

(888)

(889) !

(890) ,

(891)

(892) #

(893) )

(894) -

(895) - *<+ #

(896) ,3 (

(897) )-! = Q #

(898) 1

(899) N

(900)

(901) #

(902) ) #

(903)

(904) !'!

(905) -# ,)

(906) N , -

(907) 1

(908)

(909) ,!) !- ,)

(910) 5

(911) -)-

(912) 1 1 ,

(913)

(914) 3 . --

(915) 1

(916)

(917) 5=

(918) p#

(919) M;3;E1

(920)

(921) --. ,N 3 -- ,1)

(922) !

(923)

(924) @ %1

(925) )

(926) *@CE3; < ?. x+3. Results > !

(927) - 5:D)-

(928) 7E*C5]+ )-!

(929) )1 1 )

(930)

(931)

(932) >? , 1

(933)

(934)

(935)

(936)

(937) ,3<

(938) Z

(939) , 579 )-

(940) 1

(941)

(942)

(943)

(944) N ,3&

(945)

(946)

(947) )

(948) -

(949) #

(950) . ,) ) - )-

(951) 1 1 ,

(952)

(953)

(954) !![

(955) (

(956) C3(

(957) !

(958)

(959) 1E5FCC,

(960) C79*E`]+)-

(961) 88.

(962)

(963)

(964)

(965)

(966) . 1

(967)

(968) !

(969) 3 !

(970) )-

(971) 1

(972)

(973)

(974) ),3?

(975) ) ) - #

(976)

(977) <<

(978) 17CDFD;C*

(979) ;=:`7;+3<<1

(980) DE*9C]+)-

(981) 3?

(982)

(983) !C7D*ED]+)-

(984) #

(985)

(986) <<

(987) E7`FCC5;1

(988) #

(989) 1 9C*5D]+CD*C9]+)-

(990) #<<

(991) A9;; AC;;;

(992) )

(993) -#

(994) ,3 Table 1. <

(995) )

(996) -

(997) ,) ) -

(998) - ,

(999)

(1000) Overall n=234

(1001) *,

(1002) + S

(1003)

(1004)

(1005) *]+ ,)

(1006)

(1007) *]+ ! *]+ ,)

(1008)

(1009)

(1010)

(1011) ! *]+ @ -#

(1012) ! , , *]+

(1013)

(1014) =

(1015)

(1016)

(1017)

(1018) - *,

(1019) +

(1020) -!

(1021) S*,

(1022) + HbA1C*]+ (

(1023) !

(1024) *]+ Oral Insulin Insulin and oral agent

(1025) - ) , *]+ Nephropathy @ *]+ @@ *]+ & ,!

(1026) '* ^!2+ !

(1027)

(1028)

(1029) *!+ S

(1030) - *]+ Aspirin <"= - Serum markers (

(1031)

(1032) *!! ^ + $$*!! ^ + $*!! ^ + <

(1033)

(1034) ^$- ( ,

(1035)

(1036) *!! ^ +. Coronary atherosclerosis CAC score = 0 CAC score > 0 (n=95) (n=139). p value. 52 ± 11 C79*E`+ C77*E`+ E9*57+ C97*_C+ CC7*9:+. 46 ± 11 95*99+ 79*7_+ C:*CD+ 99*9_+ 97*9E+. 56 ± 10 D5*__+ 7`*E:+ 7_*5_+ DD*`C+ `;*E;+. M;3;;C 0.01 M;3;;C 0.22 M;3;;C 0.44. 13 ± 11 40 ±15 7.8 ± 1.7. 10 ± 8 36 ± 13 7.7 ± 1.6. 14 ± 12 42 ± 15 7.9 ± 1.7. M;3;;C 0.08 0.57. :D*7:+ D`*95+ 95*C:+ 9:*5C+ 75*C9+ 77*C9+ :D*7:+ 28 ± 6 100 ± 14. 7E*7`+ 7E*7`+ CE*C_+ CC*C5+ D*D+ CC*C5+ 57*59+ 28 ± 6 98 ± 14. E9*7D+ E9*7D+ 5`*CD+ 7`*5`+ 57*C`+ 55*C_+ __*9:+ 28 ± 5 101 ±14. 0.76 0.66 0.48 0.005 0.12 0.36 M;3;;C 0.73 0.14. E7*57+ `;*7;+ CC:*E;+. CC*C5+ C5*C7+ 7C*77+. 95*7;+ E:*95+ :`*_7+. 0.001 M;3;;C M;3;;C. 4.7 ± 1.1 3.0 ± 1.0 1.4 ± 0.6 3.6 ± 1.3 1.7 ± 1.1. 4.6 ± 1.0 2.9 ± 1.0 1.4 ± 0.5 3.5 ± 1.2 1.6 ± 1.1. 4.8 ± 1.2 3.0 ± 1.0 1.4 ± 0.6 3.8 ± 1.3 1.8 ± 1.2. 0.12 0.39 0.55 0.07 0.13. 89.

(1037) Chapter 7.

(1038)

(1039) Overall n=234 Two-dimensional echocardiography $

(1040)

(1041) - - *]+ $

(1042) # !

(1043) *! + $

(1044) , # !

(1045) *! + "1#

(1046) *!^

(1047) + 1#

(1048) *!^

(1049) + "^ ("#

(1050) *!

(1051) + @*!^

(1052) + @*!^

(1053) + @^ "|*!^

(1054) + "^"| $ ,- *]+ $!

(1055) '*^!2+ $$*]+. 68 ± 10. Coronary atherosclerosis CAC score = 0 CAC score > 0 (n=95) (n=139) 68 ± 9. 118 ± 29 117 ± 25 39 ± 17 38 ± 14 0.71 ± 0.18 0.75 ± 0.21 0.69 ± 0.19 0.66 ± 0.18 1.08 ± 0.35 1.20 ± 0.41 179 ± 55 175 ± 46 0.52 ± 0.11 0.52 ± 0.11 0.41 ± 0.10 0.43 ± 10 1.30 ± 0.35 1.26 ± 0.32 6.37 ± 2.13 7.05 ± 2.34 12.56 ± 6.73 12.16 ± 6.67 CE:*_:+ E7*57+ 83 ± 22 80 ± 19 -17.0 ± 3.0 -18.0 ± 2.8. p value. 68 ± 11. 0.90. 119 ± 32 39 ± 19 0.69 ± 0.16 0.72 ± 0.19 1.00 ± 0.29 181 ± 61 0.52 ±0.12 0.40 ± 0.10 1.34 ± 0.36 5.89 ± 1.83 12.84 ± 6.78 C;E*9E+ 85 ± 24 -16.3 ± 3.0. 0.72 0.69 0.06 0.04 M;3;;C 0.38 0.87 0.05 0.08 M;3;;C 0.45 0.002 0.07 M;3;;C. O <"

(1056) #

(1057) -

(1058) [,!

(1059) O S

(1060)

(1061) !

(1062). O (

(1063)

(1064)

(1065) - -!

(1066) O "

(1067) ,O "|

(1068) , )!

(1069) O $ O$

(1070) , ) )

(1071) O$$ 1

(1072) , ) )

(1073) O$

(1074) %#

(1075) O@@ ) ,

(1076) ) ,O @# ) ! ,#

(1077)

(1078) O@ )

(1079) )

(1080) #

(1081)

(1082)

(1083)

(1084) 3 * Blood pressure AC9;^D;!!

(1085) !

(1086) 1 -,)

(1087)

(1088) #

(1089) !

(1090) -

(1091)

(1092)

(1093) #

(1094) AE3;!! ^$

(1095)

(1096)

(1097) 1

(1098) !

(1099) - .

(1100)

(1101)

(1102) )

(1103) -

(1104) $"> 1 1 ! ! *_: ± C;]+

(1105) $!

(1106) '1:7 ± 22 g/m23(

(1107) !

(1108) $1=C`3; ± 3.0%. ,- 1

(1109) #

(1110) CE:*_:]+)-

(1111) 3. Clinical data <

(1112) )

(1113) -

(1114) ,) ) -

(1115) )

(1116)

(1117)

(1118) (

(1119) C3 !)

(1120) )-

(1121) 1 ,

(1122)

(1123) *BDE+ )-

(1124) 1 ,

(1125)

(1126) *BC7D+1

(1127)

(1128) N ,

(1129)

(1130) -

(1131)

(1132) *pM;3;;C !) +O- )-

(1133) 1 ,

(1134)

(1135) !

(1136)

(1137) Z

(1138) , ,)

(1139)

(1140) ,)

(1141)

(1142)

(1143)

(1144) !

(1145) - ) , ) ,

(1146) ) ,*pM;3;C . !) +3 90.

(1147)

(1148)

(1149)

(1150)

No results found